Anzahl der Publikationen: 11
Zeitschriftenartikel
Metzgeroth, G.; Schwaab, J.; Naumann, N.; Haferlach, C.; Jawhar, M.; Horny, H.-P.; Dirk, J.; Kratz-Albers, K.; Krämer, D.; Mayer, S.; Storch, N.; Burchert, A.; Haferlach, T.; Cross, N. C. P.; Hofmann, W.-K.; Fabarius, A. und Reiter, A.
(2017):
Clinical characteristics and treatment with ruxolitinib in patients with PCM1-JAK2 and BCR-JAK2 positive myeloid/lymphoid neoplasms with eosinophilia.
In: Oncology Research and Treatment, Bd. 40: S. 196
Valent, P.; Akin, C.; Hartmann, K.; George, T. I.; Sotlar, K.; Peter, B.; Gleixner, K. V.; Blatt, K.; Sperr, W. R.; Manley, P. W.; Hermine, O.; Kluin-Nelemans, H. C.; Arock, M.; Horny, H.-P.; Reiter, A. und Gotlib, J.
(2017):
Midostaurin: a magic bullet that blocks mast cell expansion and activation.
In: Annals of Oncology, Bd. 28, Nr. 10: S. 2367-2376
Valent, P.; Sotlar, K.; Blatt, K.; Hartmann, K.; Reiter, A.; Sadovnik, I.; Sperr, W. R.; Bettelheim, P.; Akin, C.; Bauer, K.; George, T. I.; Hadzijusufovic, E.; Wolf, D.; Gotlib, J.; Mahon, F.-X.; Metcalfe, D. D.; Horny, H.-P. und Arock, M.
(2017):
Proposed diagnostic criteria and classification of basophilic leukemias and related disorders.
In: Leukemia, Bd. 31, Nr. 4: S. 788-797
Reiter, A.; Kluin-Nelemans, H. C.; George, T.; Akin, C.; DeAngelo, D. J.; Hermine, O.; Awan, F.; Hexner, E.; Mauro, M.; Schwaab, J.; Jawhar, M.; Sternberg, D.; Berkowitz, N.; Niolat, J.; Labed, A. Huntsman; Hartmann, K.; Horny, H.-P.; Valent, P. und Gotlib, J.
(2017):
Pooled Survival Analysis Of Midostaurin Clinical Study Data (D2201+A2213) In Patients With Advanced Systemic Mastocytosis Compared With Historical Controls.
In: Haematologica, Bd. 102: S. 321-322
Jawhar, M.; Schwaab, J.; Hausmann, D.; Clemens, J.; Naumann, N.; Henzler, T.; Horny, H.-P.; Sotlar, K.; Schoenberg, S. O.; Cross, N. C. P.; Fabarius, A.; Hofmann, W.-K.; Valent, P.; Metzgeroth, G. und Reiter, A.
(2016):
Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis.
In: Leukemia, Bd. 30, Nr. 12: S. 2342-2350
Jawhar, M.; Schwaab, J.; Meggendorfer, M.; Naumann, N.; Kluger, S.; Horny, H.-P.; Sotlar, K.; Haferlach, T.; Fabarius, A.; Hofmann, W.-K.; Reiter, A. und Metzgeroth, G.
(2016):
Mast cell leukemia: clinical heterogeneity, molecular aberrations and prognostic factors.
In: Oncology Research and Treatment, Bd. 39: S. 24
Naumann, N.; Jawhar, M.; Schwaab, J.; Metzgeroth, G.; Khaled, N.; Horny, H.-P.; Sotlar, K.; Valent, P.; Haferlach, C.; Göhring, G.; Schlegelberger, B.; Meggendorfer, M.; Cross, N. C. P.; Hofmann, W. K.; Reiter, A. und Fabarius, A.
(2016):
Incidence and prognostic impact of cytogenetic aberrations in systemic mastocytosis.
In: Oncology Research and Treatment, Bd. 39: S. 25
Jawhar, M.; Schwaab, J.; Hausmann, D.; Clemens, J.; Naumann, N.; Henzler, T.; Horny, H.-P.; Sotlar, K.; Schoenberg, S. O.; Cross, N. C. P.; Fabarius, A.; Hofmann, W.-K.; Valent, P.; Metzgeroth, G. und Reiter, A.
(2016):
Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis.
In: Oncology Research and Treatment, Bd. 39: S. 232
Tzankov, A.; Sotlar, Karl; Muhlematter, D.; Theocharides, A.; Went, P.; Jotterand, M.; Horny, H.-P. und Dirnhofer, S.
(2008):
Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3.
In: Journal of Clinical Pathology, Bd. 61: S. 958-961
[PDF, 1MB]
Schumacher, U.; Zahler, Stefan; Horny, H.-P.; Heidemann, Günter; Skirnisson, K. und Welsch, U.
(1993):
Histological investigations on the thyroid glands of marine mammals (Phoca vitulina, Phocoena phocoena) and the possible implications of marine pollution.
In: Journal of wildlife diseases, Bd. 29, Nr. 1: S. 103-108
[PDF, 896kB]
Diese Liste wurde am
Sat Nov 23 23:45:30 2024 CET
erstellt.